Clinical trial

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

NCT00613249

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-11-01

PhasePHASE1

Study timeline

Study start (unknown)2007-11-01Date precision: month

Registry last updated2009-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Dapivirine Gel 4750, 0.05%, 2.5gDRUG

Dapivirine Gel 4789, 0.05%, 2.5gDRUG

HEC-based Placebo GelDRUG

Sponsors & collaborators

International Partnership for Microbicides, Inc.lead sponsor

Mapped research locations

AntwerpBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00613249 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.